Browsing Tag
SJP-002C
2 posts
Sen-Jam’s SJP-002C gets FDA-ready CMC milestone as investors eye late-stage trial momentum
Sen-Jam finalizes NDA-ready CMC deliverables for SJP-002C with KVK Tech and expands investor engagement, positioning for Phase 2b/3 trials.
Sen-Jam Pharmaceutical and KVK Tech clear final hurdle for SJP-002C, setting the stage for pivotal clinical trials
Sen-Jam Pharmaceutical and KVK Tech finalize CMC deliverables for SJP-002C, positioning the novel immunoregulator for pivotal Phase 2b/3 trials.